PhRMA Statement on Health Care Reform

Washington, D.C. (February 22, 2010) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today released the following statement:

“We remain committed to health care reform done in a fair and smart way. We continue to believe that all Americans should have access to high-quality, affordable health care coverage and services.

PhRMA Statement on President’s 2011 Budget Proposal

Washington, D.C. (February 2, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today on the White House’s fiscal year 2011 budget:

“We look forward to thoroughly reviewing the President’s budget proposal, but we are encouraged by the Administration’s increased commitment to science, technology and innovation, including biomedical research.

PhRMA Statement Regarding Minnesota-Based Innovation

Washington, D.C. (January 25, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Assistant General Counsel Marjorie Powell issued the following statement today regarding the benefits of Minnesota-based innovation to patients and public health:

“From PhRMA’s perspective, disease is our common enemy.

PhRMA Statement on Patent Settlements

Washington, D.C. (January 13, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President and General Counsel Diane Bieri issued the following statement today about a Federal Trade Commission report on settlements between brand-name and generics companies:

“The Federal Trade Commission’s report on patent settlements misrepresents legal agreements that can help to resolve expensive patent disputes, thereby fostering innovation and improving access to medicines.

Partnership for Prescription Assistance Celebrates Milestone Helping More Than 6 Million Uninsured Patients

Harrisburg, PA (October 22, 2009) — After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania. The PPA is a nationwide effort sponsored by America’s pharmaceutical research and biotechnology companies that links uninsured and financially struggling Americans to programs that provide prescription medicine for free or nearly free.

PhRMA Statement on the Passing of Sen. Ted Kennedy

Washington, D.C. (August 26, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO Billy Tauzin issued the following statement today regarding the death of Sen. Ted Kennedy:

“We share the nation’s sadness in mourning the loss of Senator Ted Kennedy, a lifelong champion for health whose leadership on such monumental legislation as the State Children’s Health Insurance Program and the Americans With Disabilities Act leaves a lasting legacy that benefits the nation as a whole.

PhRMA Statement on Surgeon General Nominee

Washington, D.C. (July 13, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President Billy Tauzin issued the following statement today regarding the nomination of Dr. Regina Benjamin to the role of surgeon general:

PhRMA Applauds Innovation, Access Policies in US-Japan Report

Washington, D.C. (July 8, 2009) – PhRMA President of International Christopher Singer issued the following statement today on this year’s annual report to President Obama and Prime Minister Aso under the U.S.-Japan Regulatory Reform and Competition Policy Initiative:

PhRMA Statement on Healthcare Reform Coalition

Washington, D.C. (May 11, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today on a new healthcare reform coalition:

PhRMA Statement on Commitment to R&D

Washington, D.C. (April 27, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin released the following statement regarding President Obama’s pledge to dedicate resources to research and development in the sciences:

"PhRMA strongly agrees with President Obama regarding the importance of a sustained commitment to research and development, not just for the good of health care and other sciences, but also for the good of the economy. We have long avowed that R&D drives innovation, and innovation drives the economy.

Pages

Subscribe to RSS - Opinion